NEWS

:Home ASG Superconductors with HZDR combine magnetic resonance imaging with proton therapy
Published On: 27-04-2021Categories: In Evidence, Press Clipping

ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology. The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting MgB2 magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.

Read the full article

Share On

NEWS

DISCOVER MORE

BE OPEN.

Discover MROpen EVO

STRESS FREE MRI.

Discover the best MRI experience

DON’T GUESS. SEE.

Discover a new clinical approach

STAND OUT.

Make your MRI center unique

THINK OUTSIDE THE BORE.

Discover research applications
Go to Top